CNMD - CONMED Corporation
68.42 0.00 (0.00%)
After hours: 4:00PM EDT
| Previous Close | 68.88 |
| Open | 68.85 |
| Bid | 68.23 x 1100 |
| Ask | 68.59 x 1000 |
| Day's Range | 68.25 - 69.29 |
| 52 Week Range | 47.41 - 69.55 |
| Volume | 90,018 |
| Avg. Volume | 165,361 |
| Market Cap | 1.919B |
| Beta | 0.14 |
| PE Ratio (TTM) | 27.50 |
| EPS (TTM) | 2.49 |
| Earnings Date | Jul 24, 2018 - Jul 30, 2018 |
| Forward Dividend & Yield | 0.80 (1.18%) |
| Ex-Dividend Date | 2018-03-14 |
| 1y Target Est | 68.00 |
- Business Wire•2 hours ago
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on July 5, 2018 to all shareholders of record as of June 15, 2018. CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology.
Markit•15 days agoSee what the IHS Markit Score report has to say about Conmed Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- GlobeNewswire•22 days ago
Market Trends Toward New Normal in Cohen & Steers, Achaogen, Ares Commercial Real Estate, CONMED, Marcus, and First Defiance Financial — Emerging Consolidated Expectations, Analyst Ratings
NEW YORK, May 02, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cohen ...
- Thomson Reuters StreetEvents•27 days ago
Edited Transcript of CNMD earnings conference call or presentation 25-Apr-18 8:30pm GMT
Q1 2018 Conmed Corp Earnings Call
- Zacks•28 days ago
CONMED (CNMD) Beats on Q1 Earnings, Lifts FY18 Guidance
CONMED (CNMD) gains on strong performance in core segments; raised guidance buoys optimism.
- Business Wire•29 days ago
CONMED Corporation Announces First Quarter 2018 Financial Results
CONMED Corporation today announced financial results for the first quarter ended March 31, 2018.
- ACCESSWIRE•29 days ago
CONMED Corporation to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / April 25, 2018 / CONMED Corporation (NASDAQ: CNMD ) will be discussing their earnings results in their Q1 Earnings Call to be held on April 25, 2018 at 4:30 PM Eastern Time. ...
- Simply Wall St.•29 days ago
Is CONMED Corporation’s (NASDAQ:CNMD) PE Ratio A Signal To Buy For Investors?
CONMED Corporation (NASDAQ:CNMD) is currently trading at a trailing P/E of 31.1x, which is lower than the industry average of 33.6x. While this makes CNMD appear like a great stockRead More...
Markit•last monthSee what the IHS Markit Score report has to say about Conmed Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding CNMD totaled $57 million.
- Business Wire•2 months ago
CONMED Corporation to Present at Two Investor Conferences in May
CONMED Corporation today announced that it will present at the following two investor conferences in May.
- Business Wire•2 months ago
CONMED Corporation to Announce First Quarter 2018 Financial Results on April 25, 2018
CONMED Corporation today announced that it will report financial results for the first quarter of fiscal year 2018 after the market close on Wednesday, April 25, 2018.
- GlobeNewswire•2 months ago
Analysis: Positioning to Benefit within AnaptysBio, MoSys, CONMED, Franklin Financial Network, Hersha Hospitality Trust, and Inovalon — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, March 20, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Markit•2 months agoSee what the IHS Markit Score report has to say about Conmed Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Market Realist•2 months agoWhy ConMed Is Expected to Report a Slight Rise in Its Net Profit Margin in 2018
ConMed (CNMD) expects to witness the positive impact of around 0.5–1.0 percentage points on its fiscal 2018 adjusted gross margin, attributable to various cost-saving initiatives. ConMed has also projected an improvement of ~0.2–0.5 percentage points in its ratio of SG&A (selling, general, and administrative) expenses to total sales for fiscal 2018 on a YoY (year-over-year) basis. ConMed also expects its 2018 R&D (research and development)-to-sales ratio to be at the higher end of the projected range of 4.5%–5%.
Market Realist•2 months agoWhy ConMed Is Expected to Report Robust Revenue Growth in 2018
ConMed (CNMD) expects to report revenue growth in the range of 5%–6.5% on a reported basis and in the range of 4.0%–5.0% on a CC (constant currency) basis for fiscal 2018. The company has projected a favorable top-line impact of 100–150 basis points, resulting from foreign exchange movements for fiscal 2018. In 2017, ConMed reported a ~4.3% YoY (year-over-year) rise in revenues on a CC basis, which would be in line with the average revenue growth in the medical technology industry.
- Market Realist•2 months ago
ConMed and Peers in 2018: Analyst Recommendations
Headquartered in Utica, New York, ConMed (CNMD) currently employs 3,100 people worldwide. In 4Q17, ConMed reported total sales close to $222.6 million, which represents a YoY (year-over-year) rise of ~7.9% on a CC (constant currency) basis and 9% on a reported basis, driven by the robust uptake of its products in the US and in international geographies. For fiscal 2017, ConMed reported total sales close to $796 million, which represents a YoY rise of ~4.3%, both on a CC and reported basis.
Markit•2 months agoSee what the IHS Markit Score report has to say about Conmed Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Over the last one-month, outflows of investor capital in ETFs holding CNMD totaled $352 million.
- Business Wire•2 months ago
CONMED Corporation Announces Annual Meeting of Shareholders
CONMED Corporation today announced that its Annual Meeting of Shareholders will be held at the Company’s corporate offices, 525 French Road, Utica, NY on Wednesday, May 23, 2018, at 2:00 p.m.
- Simply Wall St.•2 months ago
Will CONMED Corporation’s (NASDAQ:CNMD) Earnings Grow In The Year Ahead?
In December 2017, CONMED Corporation (NASDAQ:CNMD) released its most recent earnings update. Generally, it seems that analyst forecasts are fairly pessimistic, with profits predicted to drop by -19.72% next yearRead More...
Markit•3 months agoSee what the IHS Markit Score report has to say about Conmed Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- Business Wire•3 months ago
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2018 to all shareholders of record as of March 15, 2018.
- GuruFocus.com•3 months ago
Conmed Corp (CNMD) Files 10-K for the Fiscal Year Ended on December 31, 2017
Conmed Corp (NASDAQ:CNMD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017.
Markit•3 months agoSee what the IHS Markit Score report has to say about Conmed Corp.
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
- Business Wire•3 months ago
CONMED Corporation to Present at the Canaccord Genuity Musculoskeletal Conference
CONMED Corporation today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Canaccord Genuity Musculoskeletal Conference at 10:30 a.m.
- Zacks•3 months ago
5 Reasons Why You Should Buy CONMED (CNMD) Stock Right Now
Strong market trends and share price performance fortify CONMED's (CNMD) foothold in the niche markets.
